Please provide your email address to receive an email when new articles are posted on . A functional precision medicine approach produced significant objective response, PFS in children with cancer.

We are in the early days of precision medicine but it is on the back of widespread gene testing that promise of this approach of treating diseases stands. And there are plenty of companies offering ...

How important are genomics tests in enhancing medicine? Very important, and I think they are becoming more important every day. The more connections that are made between genes, disease and drugs, and ...

In December 2022, the American College of Medical Genetics and Genomics made a recommendation that all expectant mothers should be offered non-invasive prenatal testing (NIPT) instead of traditional ...

VANCOUVER, British Columbia & FOUNTAIN VALLEY, Calif.--(BUSINESS WIRE)--Contextual Genomics, a leading cancer genomics company, and Lab Genomics, a personalized medicine company providing state of the ...

Visible Genomics, a Chicago-area genetics testing company, has announced the launch of a new non-invasive genetic eye test that determines a patient's likelihood of contracting age-related macular ...

Editor’s note: LimeLight is a regular feature from WRAL TechWire offering another means of publishing noteworthy news. Be sure to check out more LimeLight worthy news at this link. GREENSBORO-The hope ...

An archway of blue and white balloons adorned the entrance of an otherwise unremarkable office building in San Jose this week, marking the grand opening of a new high-tech laboratory for Kaiser ...

In a medical exam room at Boston's Brigham and Women's Hospital, Dr. Robert C. Green goes over a menu of DNA tests with a new patient. "So based on your physical examination, your medical history and ...

Combining GeneDx’s industry-leading rare disease data asset and Fabric Genomics’ AI-powered platform furthers the Company’s leadership and creates an unrivaled platform to deliver global access to ...

Investors seeking a potentially explosive play in the growing genomic mapping sector ought to consider Bionano Genomics (NASDAQ:BNGO) stock. Source: Connect world / Shutterstock.com Readers are ...

But from a regulatory standpoint, Sure Genomics is treading on thin ice. The FDA has warned similar companies about telling people their disease risk or how their bodies might respond to a drug. Sure ...